|Outcomes||Comparison||Number of studies (number of patients)||Standardised mean difference (95% CI)|
|*Abbreviations defined in glossary; RBI, NNT, and CI calculated from data in article. Outcomes were analysed using either a random (†) or fixed (‡) effects model.§Not significant.|
|Pain||Glu v NSAIDs||3 (292)||0.86 (0.58 to 1.14)‡|
|Glu v pl||7 (471)||1.40 (0.65 to 2.14)†|
|Function||Glu v NSAIDs||2 (364)||0.32 (−0.28 to 0.92)†§|
|Glu v pl||3 (563)||0.63 (−0.04 to 1.29)†§|
|Weighted event rates (number of studies)||RBI (95% CI)||NNT (CI)|
|Glu v pl||51.8% v 34.2% (2)||52% (20 to 91)‡||6 (4 to 13)‡|
Review: glucosamine is more effective than selected non-steroidal anti-inflammatory drugs and placebo for reducing pain and more effective than placebo for improving function in patients with osteoarthritis
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>
EBN Online Journal Club
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.